Therapeutics Targeting the Core Apoptotic Machinery

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Cancer cells often rely on anti-apoptotic proteins for survival.
• Targeting these proteins offers a direct method for cancer cell death.
• Apoptosis pathways are increasingly recognized as valid anti-cancer therapeutic targets.

Purpose of the Study:

• To review the main apoptosis pathways and key molecular targets in cancer drug development.
• To discuss the clinical progress of agents targeting apoptosis.
• To explore resistance mechanisms and combination strategies for apoptosis-targeting therapeutics.

Main Methods:

• Literature review of scientific publications and clinical trial data.
• Analysis of molecular targets within intrinsic and extrinsic apoptosis pathways.
• Examination of emerging resistance factors and combinatorial treatment approaches.

Main Results:

• Several agents targeting apoptosis pathways are in clinical development.
• Key molecular targets include proteins in both mitochondrial and death receptor pathways.
• Emerging resistance factors necessitate the exploration of combination therapies.

Conclusions:

• Targeting apoptosis pathways represents a significant advancement in anti-cancer therapeutics.
• Understanding resistance mechanisms is crucial for optimizing treatment efficacy.
• Combination strategies hold promise for overcoming resistance and enhancing treatment outcomes.